Codiak Biosciences Revenue, Growth & Competitor Profile

DBA CODIAK BIOSCIENCES, INC. HEALTH AND WELFARE BENEFIT PLAN

Company Profile & Annual Report for Codiak Biosciences

Access the complete profile.

Codiak Biosciences Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	35 Cambridgepark Dr Ste 500 Cambridge, MA 02140

Note: Revenues for privately held companies are statistical evaluations.


Codiak Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Codiak Biosciences's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Codiak Biosciences is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Codiak Biosciences Annual Revenue and Growth Rate

Codiak Biosciences	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Codiak Biosciences's revenues are gauged from an analysis of company filings.

Codiak Biosciences's Income Statement (based on Industry Averages)

Codiak Biosciences P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Codiak Biosciences is developing and marketing. Codiak Biosciences doesn't have any recent trademark applications, indicating Codiak Biosciences is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EXOIL-12 Biological preparations comprising exosomes for therapeutic applications in the areas of oncology, immune-based diseases, metabolic and fibrotic disorders, neurological disorders, vaccination, and rare diseases	07/30/2020
ENGEX - SIRNA Biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications in the areas of oncology, immune-based diseases, metabolic and fibrotic disorders, neurological disorders, vaccination, and rare diseases	07/17/2020
ENGEX - AAV Biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications in the areas of oncology, immune-based diseases, metabolic and fibrotic disorders, neurological disorders, vaccination, and rare diseases	07/17/2020

See all trademarks and details in the Full Report.

Market Share of Codiak Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Codiak Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Codiak Biosciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Future Competition: Codiak Biosciences's Fastest Growing Competitors

These companies are in the same general field as Codiak Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)